Ayushman Bharat: Over 0.7 mn Covid treatments authorised from Apr'20-Jul'21

Under the Centre's Ayushman Bharat scheme over 2 million tests and 725,000 Covid-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021, officials said

coronavirus, covid-19, vaccine, vaccination, elderly
A healthcare volunteer inoculates an elderly woman with a Covid-19 vaccine dose at her home in Mumbai, Thursday, Aug. 5, 2021. (PTI Photo/ Kunal Patil)
Press Trust of India New Delhi
2 min read Last Updated : Aug 18 2021 | 9:24 PM IST

Under the Centre's Ayushman Bharat scheme over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021, officials said.

Since the launch of the health insurance scheme on September, 23, 2018, over 2 crore hospital admissions estimated to be worth more than Rs 25,000 crore have been authorised across the country under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (AB-PMJAY) till August 17.

Around 16.50 crore beneficiaries have been verified and provided with Ayushman cards.

On an average, approximately 28 beneficiaries are verified per minute and atleast 20 pre-authorisations take place per minute under the scheme, an official source said.

"Under the Ayushman Bharat health insurance scheme, over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021.The insurance scheme allows the beneficiaries to avail free testing and treatment across all empanelled -- both public and private -- hospitals," an official said.

Also, women account for 45 per cent of the total authorised hospital admissions, the sources said.

General medicine, obstetrics and gynaecology, general surgery, medical oncology and opthamology are among top specialities and procedures availed by the women beneficiaries under the scheme.

Also 50 per cent of the around 11 crore individuals verified under the PM-JAY IT system are women.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAyushman BharatCoronavirus Tests

First Published: Aug 18 2021 | 9:21 PM IST

Next Story